Recent developments in the synthesis of antitumor-active glycyrrhetinic acid derivatives

Mini-Reviews in Organic Chemistry

Volumn 11, Issue 3, 2014, Pages 253-261

  Csuk, René ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antitumor activity; Apoptosis; Glyccyrhizin; Glycyrrhetinic acid

Indexed keywords

CHEMOTHERAPY; DRUG PRODUCTS; TUMORS;

ACID DERIVATIVE; ANTI-TUMORS; ANTITUMOUR ACTIVITY; DRUG-RESISTANCE; GLYCCYRHIZIN; GLYCYRRHETINIC ACIDS; HUMAN TUMOR CELLS; MALIGNANT TUMORS; NATURAL PRODUCTS; TUMOUR CELLS;

CELL DEATH;

EID: 84911447201     PISSN: 1570193X     EISSN: 18756298     Source Type: Journal    
DOI: 10.2174/1570193x1103140915105049     Document Type: Article

References (134)

1. Connolly, J.D.; Hill, R.A. Triterpenoids. Nat. Prod. Rep., 2010, 27, 79-132.
2. Lallemand, B.; Gelbcke, M.; Dubois, J.; Prevost, M.; Jabin, I.; Kiss, R. Structure-Activity Relationship Analyses of Glycyrrhetinic Acid Derivatives as Anticancer Agents. Mini-Rev. Med. Chem., 2011, 11, 881-887.
3. Patlolla, J.M.R.; Ravo, C.V. Triterpenpoids for Cancer Prevention and Treatment: Current statuts and future prospects. Curr. Pharm. Biotechnol., 2012, 13, 147-155.
4. Mayur, Y.C.; Peters, G.J.; Prasad, V.V.S.R.; Lemos, C.; Sathish, N. K. Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells. Curr. Cancer Drug Targets, 2009, 9, 298-306.
5. Goldberg, E.D.; Amosova, E.N.; Zueva, E.P.; Razina, T.G.; Krylova, S.G.; Zorikov, P.S. Licorice preparations improve efficiency of chemotherapy and surgical treatment of transplanted tumors. B. Exp. Biol. Med., 2008, 145, 252-255.
6. Niu, T.; Yang, J.; Zhang, L.; Cheng, X.; Li, K.; Zhou, G. Research advances on anticancer effect of licorice. Curr. Bioact. Compd., 2009, 5, 234-242.
7. Nieman, C. Licorice. Adv. Food Res., 1957, 7, 339-81.
8. Gibson, M.R. Glycyrrhiza in Old and New Perspectives. Lloydia, 1978, 41, 348-354.
9. Shibata, S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi, 2000, 120, 849-862.
10. Graebin, C.S.; Verli, H.; Guimaraes, J.A. Glycyrrhizin and Glycyrrhetic Acid: Scaffolds to Promising New Pharmacologically Active Compounds. J. Brazil. Chem. Soc., 2010, 21, 1595-1615.
11. Kitagawa, I. Licorice root. A-natural sweetener and an important ingredient in Chinese medicine. Pure Appl. Chem., 2002, 74, 1189-1198.
12. Fiore, C.; Eisenhut, M.; Ragazzi, E.; Zanchin, G.; Armanini, D. A history of the therapeutic use of liquorice in Europe. J. Ethnopharmacol., 2005, 99, 317-324.
13. Baltina, L.A. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr. Med. Chem., 2003, 10, 155-171.
14. Zhang, Q.Y.; Ye, M. Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice). J. Chromatogr. A, 2009, 1216, 1954-1969.
15. Wang, Y.C.; Yang, Y.S. Simultaneous quantification of flavonoids and triterpenoids in licorice using HPLC. J. Chromatogr. B, 2007, 850, 392-399.
16. Cordell, G.A.; Colvard, M.D. Natural Products and Traditional Medicine: Turning on a Paradigm. J. Nat. Prod., 2012, 75, 514-525.
17. Farnsworth, N.R.; Akerele, O.; Bingel, A.S.; Soejarto, D.D.; Guo, Z.G. Medicinal-Plants in Therapy. B. World Health Organ., 1985, 63, 965-981.
18. Salvador, J.A.R.; Moreira, V.M.; Goncalves, B.M.F.; Leal, A.S.; Jing, Y. Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugs. Nat. Prod. Rep., 2012, 29, 1463-1479.
19. Sheng, H.M.; Sun, H.B. Synthesis, biology and clinical significance of pentacyclic triterpenes: a multitarget approach to prevention and treatment of metabolic and vascular diseases. Nat. Prod. Rep., 2011, 28, 543-593.
20. Van Laecke, S.; Vanholder, R. Bardoxolone Methyl, Chronic Kidney Disease, and Type 2 Diabetes. New Engl. J. Med., 2011, 365, 1745-1745.
21. Kim, E.H.; Deng, C.X.; Sporn, M.B.; Liby, K.T. CDDOImidazolide Induces DNA Damage, G2/M Arrest and Apoptosis in BRCA1-Mutated Breast Cancer Cells. Cancer Prev. Res., 2011, 4, 425-434.
22. Townson, J.L.; MacDonald, I.C.; Liby, K.T.; Mackenzie, L.; Dales, D.W.; Hedley, B.D.; Foster, P.J.; Sporn, M.B.; Chambers, A.F. The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis. Clin. Exp. Metastas., 2011, 28, 309-317.
23. Dang, Z.; Huang, L.; Chen, C.H. Hiv-1 Maturation Inhibitors: An Update. Drug Future, 2009, 3, 797-802.
24. Dang, Z.; Lai, W.H.; Qian, K.D.; Ho, P.; Lee, K.H.; Chen, C.H.; Huang, L. Betulinic Acid Derivatives as Human Immunodeficiency Virus Type 2 (HIV-2) Inhibitors. J. Med. Chem., 2009, 52, 7887-7891.
25. Tolstikov, G.A.; Baltina, L.A.; Serdyuk, N.G. Glycyrrhetic acid. Khim.-Farm. Zh., 1998, 32, 5-14.
26. Mukherjee, R.; Kumar, V.; Srivastava, S.K.; Agarwal, S.K.; Burman, A.C. Betulinic acid derivatives as anticancer agents: structure-activity relationship. Anti-Cancer Agents Med. Chem., 2006, 6, 271-279.
27. Feng, J.H.; Chen, W.; Zhao, Y.; Ju, X.L. Anti-tumor activity of oleanolic, ursolic and glycyrrhetinic acid. Open Nat. Prod. J., 2009, 2, 48-52.
28. Plohmann, B.; Bader, G.; Hiller, K.; Franz, G. Immunomodulatory and antitumoral effects of triterpenoid saponins. Pharmazie, 1997, 52, 953-957.
29. Ryu, S.Y.; Choi, S.U.; Lee, S.H.; Lee, C.O.; No, Z.; Ahn, J.W. Antitumor triterpenes from medicinal plants. Arch. Pharmacal. Res., 1994, 17, 375-377.
30. Kondratenko, R.M.; Baltina, L.A.; Baschenko, N.Z.; Tolstikov, G.A. Synthesis and immunomodulating activity of new glycopeptides of glycyrrhizic acid containing residues of Lglutamic acid. Russ. J. Bioorg. Chem., 2006, 32, 595-601.
31. Mikhailova, L.R.; Baltina, L.A.; Kondratenko, R.M.; Kunert, O.; Spirikhin, L.V.; Galin, F.Z.; Tolstikov, G.A. Synthesis and highresolution nmr spectra of A-nor-derivatives of 11- deoxyglycyrrhetic acid. Chem. Nat.Compd., 2006, 42, 553-557.
32. Harada, S. The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope. Biochem. J., 2005, 392, 191-199.
33. Ikeda, T.; Yokomizo, K.; Okawa, M.; Tsuchihashi, R.; Kinjo, J.; Nohara, T.; Uyeda, M. Anti-herpes virus type 1 activity of oleanane-type triterpenoids. Biol. Pharm. Bull., 2005, 28, 1779-1781.
34. Cinatl, J.; Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H.; Doerr, H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet, 2003, 361, 2045-2046.
35. Mendes-Silva, W.; Assafim, M.; Ruta, B.; Monteiro, R.Q.; Guimaraes, J.A.; Zingali, R.B. Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor. Thromb. Res., 2003, 112, 93-98.
36. Nakata, N.; Kira, Y.; Yabunaka, Y.; Takaoka, K. Prevention of venous thrombosis by preoperative glycyrrhizin infusion in a rat model. J. Orthop. Sci., 2008, 13, 456-462.
37. Ram, A.; Mabalirajan, U.; Das, M.; Bhattacharya, I.; Dinda, A.K.; Gangal, S.V.; Ghosh, B. Glycyrrhizin alleviates experimental allergic asthma in mice. Int. Immunopharmacol., 2006, 6, 1468-1477.
38. Kalaiarasi, P.; Pugalendi, K.V. Antihyperglycemic effect of 18 beta-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin- diabetic rats. Eur. J. Pharmacol., 2009, 606, 269-273.
39. Schrofelbauer, B.; Raffetseder, J.; Hauner, M.; Wolkerstorfer, A.; Ernst, W.; Szolar, O.H.J. Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling. Biochem. J., 2009, 421, 473-482.
40. Wolkerstorfer, A.; Kurz, H.; Bachhofner, N.; Szolar, O.H.J. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antivir. Res., 2009, 83, 171-178.
41. Ukil, A.; Biswas, A.; Das, T.; Das, P.K. 18 beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B. J. Immunol., 2005, 175, 1161-1169.
42. Rossi, T.; Benassi, L.; Magnoni, C.; Ruberto, A.I.; Coppi, A.; Baggio, G. Effects of glycyrrhizin on UVB-irradiated melanoma cells. In Vivo, 2005, 19, 319-322.
43. Mollica, L.; De Marchis, F.; Spitaleri, A.; Dallacosta, C.; Pennacchini, D.; Zamai, M.; Agresti, A.; Trisciuoglio, L.; Musco, G.; Bianchi, M.E. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem. Biol., 2007, 14, 431-441.
44. Mauricio, I.; Francischetti, B.; Monteiro, R.Q.; Guimaraes, J.A. Identification of glycyrrhizin as a thrombin inhibitor. Biochem. Bioph. Res. Commun., 1997, 235, 259-263.
45. Harwansh, R.K.; Patra, K.C.; Pareta, S.K.; Singh, J.; Biswas, R. Pharmacological studies on glycyrrhiza glabra: a review. Pharmacol. Online, 2011, 2, 1032-1038.
46. De Clercq, E. Current lead natural products for the chemotherapy of human immunodefiency virus (HIV) infection. Med. Res. Rev., 2000, 20, 323-349.
47. Badam, L. Ammonium salt of glycyrrhizic acid as an antiviral. Natl. Med. J. India, 1997, 10, 98-98.
48. Badam, L. In vitro studies on the effect of glycyrrhizin from Indian Glycyrrhiza glabra Linn. on some RNA and DNA viruses. Ind. J. Pharmacol., 1994, 26, 194-9.
49. Jeong, H.G.; You, H.J.; Park, S.J.; Moon, A.R.; Chung, Y.C.; Kang, S.K.; Chun, H.K. Hepatoprotective effects of 18-betaglycyrrhetinic acid on carbon tetrachloride-induced liver injury: Inhibition of cytochrome P450 2E1 expression. Pharmacol Res., 2002, 46, 221-227.
50. Nakano, N.; Kato, H.; Suzuki, H.; Nakao, K.; Yano, S.; Kaneoka, M. Enzyme immunoassay for glycyrrhetic acid and glycyrrhezin. 1. Enzyme immunoassay for glycyrrhetic acid. Yakuri Chiryo, 1980, 8, 4167-4170.
51. Sakiya, Y.; Akada, Y.; Kawano, S.; Miyauchi, Y. Rapid Estimation of Glycyrrhizin and Glycyrrhetinic Acid in Plasma by High-Speed Liquid-Chromatography. Chem. Pharm. Bull., 1979, 27, 1125-1129.
52. Okamura, N.; Miyauchi, H.; Choshi, T.; Ishizu, T.; Yagi, A. Simultaneous determination of glycyrrhizin metabolites formed by the incubation of glycyrrhizin with rat feces by semi-micro highperformance liquid chromatography. Biol. Pharm. Bull., 2003, 26, 658-661.
53. Akao, T.; Akao, T.; Hattori, M.; Kanaoka, M.; Yamamoto, K.; Namba, T.; Kobashi, K. Hydrolysis of Glycyrrhizin to 18-Beta- Glycyrrhetyl Monoglucuronide by Lysosomal-Beta-DGlucuronidase of Animal Livers. Biochem. Pharmacol., 1991, 41, 1025-1029.
54. Akao, T.; Akao, T.; Kobashi, K. Metabolism of Glycyrrhetic Acid by Rat-Liver Microsomes - Glycyrrhetinate Dehydrogenase. Biochim. Biophys. Acta, 1990, 1042, 241-246.
55. Akao, T.; Aoyama, M.; Akao, T.; Hattori, M.; Imai, Y.; Namba, T.; Tezuka, Y.; Kikuchi, T.; Kobashi, K. Metabolism of Glycyrrhetic Acid by Rat-Liver Microsomes-II. 22-Alpha-Hydroxylation and 24-Hydroxylation. Biochem. Pharmacol., 1990, 40, 291-296.
56. Agarwal, R.; Wang, Z.Y.; Mukhtar, H. Inhibition of Mouse Skin Tumor Initiating Activity of Dmba by Chronic Oral-Feeding of Glycyrrhizin in Drinking-Water. Nutr. Cancer, 1991, 15, 187-193.
57. Ohigashi, H.; Takamura, H.; Koshimizu, K.; Tokuda, H.; Ito, Y. Search for Possible Antitumor Promoters by Inhibition of 12-OTetradecanoylphorbol- 13-Acetate-Induced Epstein-Barr Virus- Activation - Ursolic Acid and Oleanolic Acid from an Antiinflammatory Chinese Medicinal Plant, Glechoma-Hederaceae L. Cancer Lett., 1986, 30, 143-151.
58. Suzuki, F.; Schmitt, D.A.; Utsunomiya, T.; Pollard, R.B. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. In Vivo, 1992, 6, 589-596.
59. Kitagawa, K.; Nishino, H.; Iwashima, A. Inhibition of the Specific Binding of 12-O-Tetradecanoylphorbol-13-Acetate to Mouse Epidermal Membrane-Fractions by Glycyrrhetic Acid. Oncology, 1986, 43, 127-130.
60. Nishino, H.; Kitagawa, K.; Iwashima, A. Antitumor-Promoting Activity of Glycyrrhetic Acid in Mouse Skin Tumor-Formation Induced by 7,12-Dimethylbenz[a]Anthracene Plus Teleocidin. Carcinogenesis, 1984, 5, 1529-1530.
61. Satomi, Y.; Nishino, H.; Shibata, S. Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anticancer Res., 2005, 25, 4043-4047.
62. Terasawa, T.; Okada, T.; Nishino, H. Antitumor-Promoter Activity of Modified Glycyrrhetinic Acid-Derivatives - Synthesis and Structure-Activity-Relationships. Eur. J. Med. Chem., 1992, 27, 689-692.
63. Zhang, W.J.; Chen, S.P.; Lu, X.; Zhou, G.C. Synthesis and Antiangiogenesis Activities of Ursolic Acid Derivatives. Chem. J. Chin. U., 2010, 31, 2206-2217.
64. Liu, D.; Meng, Y.Q.; Zhao, J.; Chen, L.G. Synthesis and anti-tumor activity of novel amide derivatives of ursolic acid. Chem. Res. Chin. U., 2008, 24, 42-46.
65. Park, H.Y.; Park, S.H.; Yoon, H.K.; Han, M.J.; Kim, D.H. Antiallergic activity of 18 betaglycyrrhetinic acid-3-O-beta-Dglucuronide. Arch. Pharm. Res., 2004, 27, 57-60.
66. Finney, R.S. H.; Somers, G.F. The Anti-Inflammatory Activity of Glycyrrhetinic Acid and Derivatives. J. Pharm. Pharmacol., 1958, 10, 613-620.
67. Finney, R.S.H.; Somers, G.F.; Wilkinson, J.H. The Pharmacological Properties of Glycyrrhetinic Acid - a New Anti- Inflammatory Drug. J. Pharm. Pharmacol., 1958, 10, 687-695.
68. Finney, R.S.H.; Tarnoky, A.L. The Pharmacological Properties of Glycyrrhetinic Acid Hydrogen Succinate (Disodium Salt). J. Pharm. Pharmacol., 1960, 12, 49-58.
69. Ohuchi, K.; Kamada, Y.; Levine, L.; Tsurufuji, S. Glycyrrhizin Inhibits Prostaglandin-E2 Production by Activated Peritoneal- Macrophages from Rats. Prostag. Leukotr. Ess., 1981, 7, 457-463.
70. Meng, Y.Q.; Ding, J.Q.; Liu, Y.; Nie, H.H.; Guan, S.; Zou, C.; Zhao, N.; Chen, H.; Cao, B. Synthesis and Anti-tumor Activity of Novel Glycyrrhetinic Acid Derivatives. Chem. Res. Chin. U., 2012, 28, 214-219.
71. Okamoto, H.; Yoshida, D.; Mizusaki, S. Inhibition of 12-OTetradecanoylphorbol- 13-Acetate-Induced Induction in Epstein- Barr Virus Early Antigen in Raji Cells. Cancer Lett., 1983, 19, 47-53.
72. Gao, Y.A.; Guo, X.; Li, X.J.; Liu, D.; Song, D.D.; Xu, Y.; Sun, M.; Jing, Y.K.; Zhao, L.X. The Synthesis of Glycyrrhetinic Acid Derivatives Containing A Nitrogen Heterocycle and Their Antiproliferative Effects in Human Leukemia Cells. Molecules, 2010, 15, 4439-4449.
73. Abe, H.; Ohya, N.; Yamamoto, K.F.; Shibuya, T.; Arichi, S.; Odashima, S. Effects of Glycyrrhizin and Glycyrrhetinic Acid on Growth and Melanogenesis in Cultured B-16 Melanoma-Cells. Eur. J. Cancer Clin. Oncol., 1987, 23, 1549-1555.
74. Hibasami, H.; Iwase, H.; Yoshioka, K.; Takahashi, H. Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells. Int. J. Mol. Med., 2006, 17, 215-219.
75. Isbrucker, R.A.; Burdock, G.A. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul. Toxicol. Pharm., 2006, 46, 167-192.
76. Zhang, M.Z.; Xu, J.; Yao, B.; Yin, H.; Cai, Q.; Shrubsole, M.J.; Chen, X.; Kon, V.; Zheng, W.; Pozzi, A.; Harris, R.C. Inhibition of 11 beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. J. Clin. Invest., 2009, 119, 876-885.
77. Rossi, T.; Castell, M.; Zandomeneghi, G.; Ruberto, A.; Benassi, L.; Magnoni, C.; Santachiara, S.; Baggio, G. Selectivity of action of glycyrrhizin derivatives on the growth of MCF-7 and HEP-2 cells. Anticancer Res., 2003, 23, 3813-3818.
78. Kondratenko, R.M.; Mustafina, S.R.; Baltina, L.A.; Galin, F.Z.; Tolstikov, G.A. Synthesis of triterpene derivatives of Dglucosamine - Modified analogs of glycyrrhizic acid. Chem. Nat. Compd., 2005, 41, 7-10.
79. Pavlova, S.I.; Uteshev, B.S.; Sergeev, A.V. Licorice root: possible mechanisms of antitoxicant, anticarcinogen, and anti-tumor properties (A Review). Pharm. Chem. J., 2003, 37, 314-317.
80. Hawthorne, S.; Gallagher, S. Liquorice and prostate cancer; Transworld Research Network; Kerala, India, 2008; pp. 1-15.
81. Hawthorne, S.; Gallagher, S. Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells. J. Pharm. Pharmacol., 2008, 60, 661-666.
82. Chintharlapalli, S.; Papineni, S.; Jutooru, I.; McAlees, A.; Safe, S. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisorne proliferator-activated receptor gamma agonists in colon cancer cells. Mol. Cancer Ther., 2007, 6, 1588-1598.
83. Chintharlapalli, S.; Papineni, S.; Konopleva, M.; Andreef, M.; Samudio, I.; Safe, S. 2-cyano-3, 12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gammadependent and -independent pathways. Mol. Pharmacol., 2005, 68, 119-128.
84. Liu, D.; Song, D.D.; Guo, G.; Wang, R.; Lv, J.L.; Jing, Y.K.; Zhao, L.X. The synthesis of 18-betaglycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells. Bioorg. Med. Chem., 2007, 15, 5432-5439.
85. Rao, G.S.R.S.; Kondaiah, P.; Singh, S.K.; Ravanan, P.; Sporn, M.B. Chemical modifications of natural triterpenes-glycyrrhetinic and boswellic acids: evaluation of their biological activity. Tetrahedron, 2008, 64, 11541-11548.
86. Tatsuzaki, J.; Taniguchi, M.; Bastow, K.F.; Nakagawa-Goto, K.; Morris-Natschke, S.L.; Itokawa, H.; Baba, K.; Lee, K.H. Antitumor agents 255: Novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents. Bioorg. Med. Chem., 2007, 15, 6193-6199.
87. Yamaguchi, H.; Akitaya, T.; Yu, T.; Kidachi, Y.; Kamiie, K.; Noshita, T.; Umetsu, H.; Ryoyama, K. Homology modeling and structural analysis of 11 beta-hydroxysteroid dehydrogenase type 2. Eur. J. Med. Chem., 2011, 46, 1325-1330.
88. Yamaguchi, H.; Noshita, T.; Yu, T.; Kidachi, Y.; Kamiie, K.; Umetsu, H.; Ryoyama, K. Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: Induction of actin disruption and tumor cell-selective toxicity. Eur. J. Med. Chem., 2010, 45, 2943-2948.
89. Yamaguchi, H.; Yu, T.; Kidachi, Y.; Akitaya, T.; Yoshida, K.; Kamiie, K.; Noshita, T.; Umetsu, H.; Ryoyama, K. Selective toxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME- 1 cells is potentially attributed to downregulation of glutathione. Biochimie, 2011, 93, 1172-1178.
90. Yamaguchi, H.; Yu, T.; Noshita, T.; Kidachi, Y.; Kamiie, K.; Yoshida, K.; Akitaya, T.; Umetsu, H.; Ryoyama, K. Ligandreceptor Interaction between Triterpenoids and the 11 beta- Hydroxysteroid dehydrogenase type 2 (11 beta HSD2) Enzyme Predicts Their Toxic Effects against Tumorigenic r/m HM-SFME-1 Cells. J. Biol. Chem., 2011, 286, 36888-36897.
91. Yu, T.; Yamaguchi, H.; Noshita, T.; Kidachi, Y.; Umetsu, H.; Ryoyama, K. Selective cytotoxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells: Potential involvement of HRas downregulation. Toxicol. Lett., 2010, 192, 425-430.
92. Nabekura, T.; Yamaki, T.; Ueno, K.; Kitagawa, S. Inhibition of Pglycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother. Pharm., 2008, 62, 867-873.
93. Nakagawa-Goto, K.; Nakamura, S.; Bastow, K.F.; Nyarko, A.; Peng, C.Y.; Lee, F.Y.; Lee, F.C.; Lee, K.H. Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: Evaluation of novel conjugates as cytotoxic agents. Bioorg. Med. Chem. Lett., 2007, 17, 2894-2898.
94. Jutooru, I.; Chadalapaka, G.; Chintharlapalli, S.; Papineni, S.; Safe, S. Induction of Apoptosis and Nonsteroidal Anti-inflammatory Drug-Activated Gene 1 in Pancreatic Cancer Cells by a Glycyrrhetinic Acid Derivative. Mol. Carcinogen., 2009, 48, 692-702.
95. Salvi, M.; Fiore, C.; Armanini, D.; Toninello, A. Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria. Biochem. Pharmacol., 2003, 66, 2375-2379.
96. Lee, C.S.; Kim, Y.J.; Lee, M.S.; Han, E.S.; Lee, S.J. 18β- Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity. Life Sci., 2008, 83, 481-489.
97. Song, D.D.; Gao, Y.; Wang, R.; Liu, D.; Zhao, L.X.; Jing, Y.K. Downregulation of c-FLIP, XIAP and Mcl-1 protein as well as depletion of reduced glutathione contribute to the apoptosis induction of glycyrrhetinic acid derivatives in leukemia cells. Cancer Biol. Ther., 2010, 9, 96-108.
98. Pang, X.; Zhang, L.; Wu, Y.; Lin, L.; Li, J.; Qu, W.; Safe, S.; Liu, M. Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor. J. Pharmacol. Exp. Ther., 2010, 335, 172-179.
99. Zhu, H.G.; Tayeh, I.; Israel, L.; Castagna, M. Different Susceptibility of Lung-Cell Lines to Inhibitors of Tumor Promotion and Inducers of Differentiation. J. Biol. Regul. Homeostat. Agents, 1991, 5, 52-58.
100. Guo, B.H.; Cheng, Y.; Wu, W.; Lin, L.P.; Lin, D.H. HPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipid. J. Liposome Res., 2012, 22, 120-127.
101. Zhang, C.N.; Wang, W.; Liu, T.; Wu, Y.K.; Guo, H.; Wang, P.; Tian, Q.; Wang, Y. M.; Yuan, Z. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomaterials, 2012, 33, 2187-2196.
102. Huang, L.; Yu, D.L.; Ho, P.; Qian, K.D.; Lee, K.H.; Chen, C.H. Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives. Bioorg. Med. Chem., 2008, 16, 6696-6701.
103. Lallemand, B.; Chaix, F.; Bury, M.; Bruyere, C.; Ghostin, J.; Becker, J.P.; Delporte, C.; Gelbcke, M.; Mathieu, V.; Dubois, J.; Prevost, M.; Jabin, I.; Kiss, R. N-(2-{3-[3,5-Bis(trifluoromethyl) phenyl]ureido}ethyl)-glycyrrhetinamide (6b): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity. J. Med. Chem., 2011, 54, 6501-6513.
104. Penna, F.; Bonelli, G.; Baccino, F.M.; Costelli, P. Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression. Curr. Med. Chem., 2010, 17, 309-320.
105. Wu, W.K.K.; Cho, C.H.; Lee, C.W.; Wu, K.; Fan, D.; Yu, J.; Sung, J.J.Y. Proteasome inhibition: A new therapeutic strategy to cancer treatment. Cancer Lett., 2010, 293, 15-22.
106. Csuk, R.; Schwarz, S.; Siewert, B.; Kluge, R.; Ströhl, D. Synthesis and Antitumor Activity of Ring Amodified Glycyrrhetinic Acid Derivatives. Z. Naturforsch. B, 2011, 66, 521-532.
107. Kondratenko, R.M.; Mustafina, S.R.; Baltina, L.A.; Vasil'eva, N.G.; Ismagilova, A.F.; Vasil'eva, E.V.; Nasyrov, K.M.; Galin, F.Z.; Tolstikov, G.A. Synthesis and antiulcer activity of 3-Oacylated glycyrrhetic acid methylates. Pharm. Chem. J., 2001, 35, 243-246.
108. Ahmad, F.B.H.; Moghaddam, M.G.; Basri, M.; Rahman, M.B.A. Anticancer Activity of 3-O-Acylated Betulinic Acid Derivatives Obtained by Enzymatic Synthesis. Biosci. Biotech. Biochem., 2010, 74, 1025-1029.
109. Kommera, H.; Kaluderovic, G. N.; Kalbitz, J.; Paschke, R. Synthesis and Anticancer Activity of Novel Betulinic acid and Betulin Derivatives. Arch. Pharm., 2010, 343, 449-457.
110. Vechia, L.D.; Gnoatto, S.C.B.; Gosmann, G. Oleanane and Ursane Derivatives and Their Importance on the Discovery of Potential Antitumour, Antiinflammatory and Antioxidant Drugs. Quim. Nova, 2009, 32, 1245-1252.
111. Urban, M.; Sarek, J.; Klinot, J.; Korinkova, G.; Hajduch, M. Synthesis of A-seco derivatives of betulinic acid with cytotoxic activity. J. Nat. Prod., 2004, 67, 1100-1105.
112. Urban, M.; Sarek, J.; Tislerova, I.; Dzubak, P.; Hajduch, M. Influence of esterification and modification of A-ring in a group of lupane acids on their cytotoxicity. Bioorg. Med. Chem., 2005, 13, 5527-5535.
113. Pozzi, A.; Capdevila, J.H. PPAR alpha Ligands as Antitumorigenic and Antiangiogenic Agents. PPAR Res., 2008, 906542.
114. Elrod, H.A.; Sun, S.Y. PPAR gamma and Apoptosis in Cancer. PPAR Res., 2008, Article ID 7041765.
115. Michalik, L.; Wahli, W. PPARs Mediate Lipid Signaling in Inflammation and Cancer. PPAR Res., 2008, 134059.
116. Logashenko, E.B.; Salomatina, O.V.; Markov, A.V.; Korchagina, D.V.; Salakhutdinov, N.F.; Tolstikov, G.A.; Vlassov, V.V.; Zenkova, M.A. Synthesis and Pro-Apoptotic Activity of Novel Glycyrrhetinic Acid Derivatives. Chem. Biol. Chem., 2011, 12, 784-794.
117. Salomatina, O.V.; Logashenko, E.B.; Korchagina, D.V.; Salakhutdinov, N.F.; Zenkova, M.A.; Vlasov, V.V.; Tolstikov, G.A. Synthesis and biological activity of novel glycyrrhetic acid derivatives. Dokl. Chem., 2010, 430, 35-38.
118. Ovesna, Z.; Vachalkova, A.; Horvathova, K.; Tothova, D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma, 2004, 5, 327-333.
119. Fiore, C.; Salvi, M.; Palermo, M.; Sinigaglia, G.; Armanini, D.; Toninello, A. On the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid. BBA Bioenergetics, 2004, 1658, 195-201.
120. Salvi, M.; Fiore, C.; Battaglia, V.; Palermo, M.; Armanini, D.; Toninello, A. Carbenoxolone induces oxidative stress in liver mitochondria, which is responsible for transition pore opening. Endocrinology, 2005, 146, 2306-2312.
121. Csuk, R.; Schwarz, S.; Kluge, R.; Ströhl, D. Does One Keto Group Matter? Structure-Activity Relationships of Glycyrrhetinic Acid Derivatives Modified at Position C-11. Arch. Pharm., 2012, 345, 28-32.
122. Csuk, R.; Schwarz, S.; Siewert, B.; Kluge, R.; Ströhl, D. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives. Eur. J. Med. Chem., 2011, 46, 5356-5369.
123. Lin, K.W.; Huang, A.M.; Hour, T.C.; Yang, S.C.; Pu, Y.S.; Lin, C.N. beta-18-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen speciesmediated p53 activation in NTUB1 cells. Bioorg. Med. Chem., 2011, 19, 4274-4285.
124. Schwarz, S.; Csuk, R. Synthesis and antitumour activity of glycyrrhetinic acid derivatives. Bioorg. Med. Chem., 2010, 18, 7458-7474.
125. Csuk, R.; Schwarz, S.; Siewert, B.; Kluge, R.; Ströhl, D. Conversions at C-30 of Glycyrrhetinic Acid and Their Impact on Antitumor Activity. Arch. Pharm., 2012, 345, 223-230.
126. Petrenko, N.I.; Petukhova, V.Z.; Shakirov, M.M.; Shul'ts, E.E.; Tolstikov, G.A. Transformations of higher terpenoids: IV. Synthesis and spectral parameters of glycyrrhetinic acid derivatives containing amino acid fragments. Russ. J. Org. Chem., 2000, 36, 982-995.
127. Shintyapina, A.B.; Shults, E.E.; Petrenko, N.I.; Uzenkova, N.V.; Tolstikov, G.A.; Pronkina, N.V.; Kozhevnikov, V.S.; Pokrovsky, A.G. Effect of nitrogen-containing derivatives of the plant triterpenes betulin and glycyrrhetic acid on the growth of MT-4, MOLT-4, CEM, and Hep G2 tumor cells. Russ. J. Bioorg. Chem., 2007, 33, 579-583.
128. Csuk, R.; Schwarz, S.; Kluge, R.; Ströhl, D. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid. Eur. J. Med. Chem., 2010, 45, 5718-5723.
129. Chadalapaka, G.; Jutooru, I.; McAlees, A.; Stefanac, T.; Safe, S. Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives. Bioorg. Med. Chem. Lett., 2008, 18, 2633-2639.
130. Csuk, R.; Schwarz, S.; Kluge, R.; Ströhl, D. Improvement of the Cytotoxicity and Tumor Selectivity of Glycyrrhetinic Acid by Derivatization with Bifunctional Aminoacids. Arch. Pharm., 2011, 344, 505-513.
131. Niesen, A.; Barthel, A.; Kluge, R.; Köwitzsch, A.; Ströhl, D.; Schwarz, S.; Csuk, R. Antitumoractive Endoperoxides from Triterpenes. Arch. Pharm., 2009, 342, 569-576.
132. Shen, L.; Lai, Y.; Zhang, Y.; Luo, X.; Yuan, S.; Zhang, L. Synthesis and anti-tumor activities of nitrate derivatives of glycyrrhetinic acid. J. China Pharm. Univ., 2008, 39, 103-107.
133. Shen, L.; Zhang, Y.; Lai, Y.; Luo, X.; Yuan, S.; Zhang, L. Synthesis and antitumor activity of nitric oxide-donating glycyrrhetinic acid derivatives coupled with nitrate moiety. J. China Pharm. Univ., 2011, 42, 34-38.
134. Decker, M. Hybrid Molecules Incorporating Natural Products: Applications in Cancer Therapy, Neurodegenerative Disorders and Beyond. Curr. Med. Chem., 2011, 18, 1464-1475.